Sign in

    GLOBUS MEDICAL (GMED)

    Q1 2025 Earnings Summary

    Reported on Jan 1, 1970 (After Market Close)
    Pre-Earnings Price$72.46Last close (May 8, 2025)
    Post-Earnings Price$60.97Open (May 9, 2025)
    Price Change
    $-11.49(-15.86%)
    MetricYoY ChangeReason

    Total Revenue

    -1.4%

    Total Revenue declined from $606.67M in Q1 2024 to $598.1M in Q1 2025, largely driven by weaker international revenue, while US revenue remained stable. The slight drop suggests that challenges abroad may have weighed on overall performance.

    United States Revenue

    0%

    US Revenue was virtually unchanged at $483.9M in Q1 2025 compared to $482.93M in Q1 2024. This consistency indicates a robust domestic market and steady customer demand, though the documents provide no further specifics.

    International Revenue

    -7.6%

    International Revenue fell from $123.74M in Q1 2024 to $114.3M in Q1 2025. This significant decline points to potential external challenges such as tougher market conditions or competitive pressures overseas, but precise business or market factors were not detailed.

    Research analysts covering GLOBUS MEDICAL.